The honor includes a stipend of $120,000 for each of five years and is given to support talented tenure-track junior faculty who have established themselves as blood cancer researchers and are on a trajectory of leadership in the field.
LLS is the largest voluntary health organization dedicated to fighting blood cancers worldwide and funds innovative research as well as a substantial career development program that aims to accelerate the professional advancement of rising stars in the research community.
Dr. Will, associate professor of oncology, of medicine, and of cell biology at Einstein, investigates hematopoietic stem cells and their role in driving two age-related and largely incurable blood cancers: acute myeloid leukemia and myelodysplastic syndromes.
Britta Will, Ph.D. 
